Abstract |
The launch of a new initiative to share data from failed clinical trials of investigational drugs for Alzheimer's disease provides both a promising opportunity to improve drug development in this field, as well as a novel mechanism to learn more from negative trials in general.
|
Authors | |
Journal | Nature reviews. Drug discovery
(Nat Rev Drug Discov)
Vol. 9
Issue 7
Pg. 499
(Jul 2010)
ISSN: 1474-1784 [Electronic] England |
PMID | 20614555
(Publication Type: Editorial)
|
Chemical References |
- Indoles
- Nootropic Agents
- latrepirdine
|
Topics |
- Alzheimer Disease
(drug therapy)
- Clinical Trials as Topic
- Clinical Trials, Phase III as Topic
- Databases, Bibliographic
- Indoles
(therapeutic use)
- Nootropic Agents
(therapeutic use)
- Treatment Failure
|